- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05642689
Evaluation of Fe Absorption From Iron Salt in Milk
November 30, 2022 updated by: Nestlé
Evaluation of Iron Absorption From Ferric Ammonium Phosphate and Ferric Pyrophosphate From an Instant Milk Drink in Young Children
The primary objective was:
- to compare iron absorption in apparently healthy children aged 3-6y from an instant full cream milk drink fortified with ferric pyrophosphate or ferric ammonium phosphate relative to ferrous sulfate as the reference fortificant.
- To compare iron absorption from ferric pyrophosphate to ferric ammonium phosphate from the milk drink
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
3 years to 6 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 3-6 years old (inclusive)
- Normal BMI for age (WHO standard)
- Apparently healthy, no metabolic or gastrointestinal disorder
- Non-anemic (WHO cut-off for respective age
- No medication or vitamin/mineral supplements will be consumed during the study
- Intake of Vitamin/mineral supplements will be discontinued 2 weeks before the start of the study
- Parents demonstrate an understanding of the given information and ability to comply with the study procedure
- Having obtained his/her parents or his/her legal representative's informed consent
Exclusion Criteria:
- With known gastrointestinal or metabolic disorder or experiencing significant blood losses over the past 6 months
- Possible to have medication during the study
- Currently participating or having participated another clinical trial during the past 3 months prior the beginning of this study
- Subject who cannot be expected to comply with treatment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: 1
Comparison of iron absorption from FAP to Ferrous sulfate in milk
|
Oral administration of a serving of iron labelled with stable isotope (2 mg Fe per serving) in 200ml of reconstituted milk once after a overnight fast.
The alternate test drink was fed on the following day in the same fashion.
The administration was repeated on day 3 and 4.
Other Names:
|
Other: 2
Comparison of iron absorption from ferric pyrophosphate to Ferrous sulfate in milk
|
Oral administration of a serving of iron labelled with stable isotope (2 mg Fe per serving) in 200ml of reconstituted milk once after a overnight fast.
The alternate test drink was fed on the following day in the same fashion.
The administration was repeated on day 3 and 4.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Determination of iron absorption from FAP and from ferric pyrophosphate relative to Ferrous sulfate
Time Frame: 14 days post isotope consumption
|
It is based on calculated amount of 58Fe and 57Fe appearing in the blood.
For that the shift of the iron isotope ratios in the blood samples collected 14 days after the last consumption of the last test drink are measured.
The calculation of circulating iron is based on blood volume and hemoglobin concentration.
For calculations of fractional absorption, 90% incorporation of the absorbed iron into red blood cells is assumed.
The relative iron absorption from FAP and from ferric pyrophosphate relative to ferrous sulfate is then calculated as follows: Relative bioavailability of a salt (RBV %) = ( Fe absorption from an iron salt/ Fe absorption from ferrous sulfate)∗ 100.
The comparison of the iron absorption from ferric pyrophosphate to that from ferric ammonium phosphate will be made by statistical analysis of data measured and calculated as described above.
|
14 days post isotope consumption
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2009
Primary Completion (Actual)
January 1, 2010
Study Completion (Actual)
March 1, 2010
Study Registration Dates
First Submitted
March 29, 2022
First Submitted That Met QC Criteria
November 30, 2022
First Posted (Estimate)
December 8, 2022
Study Record Updates
Last Update Posted (Estimate)
December 8, 2022
Last Update Submitted That Met QC Criteria
November 30, 2022
Last Verified
November 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 09.07NRC
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
University of PennsylvaniaActive, not recruitingHealthy | Healthy AgingUnited States
-
Chalmers University of TechnologyGöteborg UniversityCompletedHealthy | Nutrition, HealthySweden
-
University of ManitobaNot yet recruitingHealthy | Healthy Diet
Clinical Trials on Iron fortified milk with iron salt labelled with 58Fe and 57Fe
-
Isabelle Herter-AeberliKamuzu University of Health Sciences; Wageningen University and Research; Sight...Completed
-
Unilever R&DObafemi Awolowo UniversityCompletedAssessment of the Bioavailability of Iron in Iron Fortified Bouillon Cubes in Healthy Nigerian WomenIron Deficiency AnemiaNigeria
-
Swiss Federal Institute of TechnologyCompletedObesity | Overweight | PregnancySwitzerland
-
University of ManitobaCompletedIntestinal Inflammation | Generation of Reactive Oxygen SpeciesCanada
-
University Rovira i VirgiliCompletedNeurodevelopmental Disorders | Lactation
-
The Rainforest CompanyMahidol University; Swiss Federal Institute of TechnologyCompletedBioavailabilityThailand
-
National Research Council, SpainCompleted
-
Wageningen UniversitySwiss Federal Institute of Technology; Unilever R&D; Universidad de Monterrey; Mexican...Completed
-
GlaxoSmithKlineCompleted
-
University of California, San FranciscoUniversity of Colorado, Denver; University of California, Davis; Post Graduate...CompletedNutrient DeficiencyIndia